Imunon
IMNN
40 hedge funds and large institutions have $16.4M invested in Imunon in 2021 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 2 closing their positions.
750% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 2
620% more capital invested
Capital invested by funds: $2.28M → $16.4M (+$14.1M)
60% more funds holding
Funds holding: 25 → 40 (+15)
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
0.04% more ownership
Funds ownership: 0.04% → 0.08% (+0.04%)
13% less call options, than puts
Call options by funds: $502K | Put options by funds: $575K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$6M |
| 2 |
Morgan Stanley
New York
|
+$3.32M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.19M |
| 4 |
BlackRock
New York
|
+$728K |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$580K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$211K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$190K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$55.8K |
| 4 |
Squarepoint
New York
|
-$50.1K |
| 5 |
CG
Cutler Group
San Francisco,
California
|
-$11.1K |
IMNN Hedge Fund Activity: Q1 2021 in Review
40 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q1 2021, worth a combined $16.4M — up 620% from $2.28M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new IMNN positions and 2 closed out — a net gain of 15 holders — while 9 added to existing stakes and 6 trimmed.
The largest buyer was Altium Capital Management, opening a new position worth an estimated $6M. The largest seller was Qube Research & Technologies (QRT), cutting an estimated $211K.
- 40 institutional investors held Imunon (IMNN) as of Q1 2021, up from 25 in Q4 2020.
- Funds reported $16.4M of Imunon stock for Q1 2021, up 620% quarter-over-quarter.
- 17 funds opened new Imunon positions in Q1 2021 and 2 closed out, a net change of +15 holders.
- The largest Imunon buyer in Q1 2021 was Altium Capital Management, an estimated $6M added.
- The largest Imunon seller in Q1 2021 was Qube Research & Technologies (QRT), an estimated $211K sold.
Based on aggregated 13F filings for Q1 2021.